<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.loc.gov/METS/ https://www.loc.gov/standards/mets/mets.xsd" OBJID="oai:wwu.de:9bce4314-8186-4ab5-94f2-ffb9fb72900f" LABEL="University of Muenster, Institutional Repository MIAMI"  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
          <mets:metsHdr CREATEDATE="2022-11-09T14:57:13">
            <mets:agent TYPE="OTHER" ROLE="OTHER" OTHERTYPE="SOFTWARE">
              <mets:name>Memory Alpha</mets:name>
            </mets:agent>
          </mets:metsHdr>
          <mets:dmdSec ID="DMD_9bce4314-8186-4ab5-94f2-ffb9fb72900f">
            <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
              <mets:xmlData>
                <mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd" version="3.7">
                  <mods:titleInfo type="uniform" lang="eng">
                    <mods:title>“In vivtro” - a 3D cell culture system to analyze the impact of probiotic E.coli Nissle 1917 on epithelial cells</mods:title>
                  </mods:titleInfo>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1216269483" altRepGroup="0">
                    <mods:namePart type="given">Jessyca</mods:namePart>
                    <mods:namePart type="family">González</mods:namePart>
                    <mods:namePart type="date">1991-</mods:namePart>
                    <mods:displayForm>González, Jessyca</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1216269483" altRepGroup="0">
                    <mods:namePart type="given">Jessyca Alexandra</mods:namePart>
                    <mods:namePart type="family">González Martinez</mods:namePart>
                    <mods:namePart type="date">1991-</mods:namePart>
                    <mods:displayForm>González Martinez, Jessyca Alexandra</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/121669874">
                    <mods:namePart type="given">Ulrich</mods:namePart>
                    <mods:namePart type="family">Dobrindt</mods:namePart>
                    <mods:namePart type="date">1970-</mods:namePart>
                    <mods:displayForm>Dobrindt, Ulrich</mods:displayForm>
                    <mods:affiliation>FB 05: Medizinische Fakultät</mods:affiliation>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">ths</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>ULB Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Landesbibliothek Münster / Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universität Münster / Universitäts- und Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:genre>doctoralThesis</mods:genre>
                  <mods:genre authority="dct">Text</mods:genre>
                  <mods:originInfo>
                    <mods:dateIssued keyDate="yes">2020</mods:dateIssued>
                    <mods:dateOther>2020-07-02</mods:dateOther>
                    <mods:issuance>monographic</mods:issuance>
                  </mods:originInfo>
                  <mods:originInfo>
                    <mods:dateIssued encoding="w3cdtf">2020-10-07</mods:dateIssued>
                    <mods:dateModified encoding="w3cdtf">2020-10-07</mods:dateModified>
                    <mods:edition>[Electronic ed.]</mods:edition>
                  </mods:originInfo>
                  <mods:language>
                    <mods:languageTerm type="code" authority="iso639-2b">eng</mods:languageTerm>
                  </mods:language>
                  <mods:physicalDescription>
                    <mods:form>electronic</mods:form>
                    <mods:reformattingQuality>access</mods:reformattingQuality>
                    <mods:internetMediaType>application/pdf</mods:internetMediaType>
                    <mods:extent>XIII, 151</mods:extent>
                    <mods:digitalOrigin>born digital</mods:digitalOrigin>
                  </mods:physicalDescription>
                  <mods:abstract lang="ger">Infektionskrankheiten sind weltweit eine Haupttodesursache. Die Zunahme der Antibiotikaresistenz macht den dringenden Bedarf an neuen therapeutischer Strategien (z.B. vorbeugende Probiotika) deutlich. E. coli Nissle 1917 (EcN) verfügt über zahlreiche Fitnessfaktoren, die für die probiotische Natur von EcN wesentlich sind. Kolon- Zelllinien und das Bioreaktor Rotating Wall Vessel (RWV) System wurden zur Analyse eingesetzt. Des bietet dynamische Kulturbedingungen um die zelluläre Antwort von Wirts-Zellen auf Bakterien zu untersuchen. Der probiotische EcN stellte die epitheliale Barrierefunktion nach einer Schädigung durch EPEC wieder her. Die vorliegende Studie trägt zum Verständnis der Mechanismen bei, die die Wechselwirkungen zwischen Wirt und Probiotika steuern. Die Verwendung von Zellkulturmodellen, die das Darmepithel besser nachbilden, eröffnen den Weg für die Entwicklung neuer, besserer Strategien zur Kontrolle der Immunantworten des Wirtes durch Probiotika.</mods:abstract>
                  <mods:tableOfContents lang="eng">List of Figures .............................................................................................................................. VI&#13;
List of Tables ............................................................................................................................... IX&#13;
Abbreviations .............................................................................................................................. X&#13;
ABSTRACT .................................................................................................................................... 1&#13;
INTRODUCTION ........................................................................................................................... 3&#13;
2.1 The human gut microbiota ............................................................................................ 3&#13;
2.2 The biological barrier..................................................................................................... 4&#13;
2.2.1 The intestinal environment: structure and function ...................................................... 4&#13;
2.2.2 The tight junctional complex .......................................................................................... 5&#13;
2.2.2.1 Junctional Adhesion Molecule A (JAM-A) ................................................................... 5&#13;
2.2.3 Mucus .............................................................................................................................. 7&#13;
2.3 The immunity of the gut ................................................................................................ 7&#13;
2.3.1 Host-microbe crosstalk ................................................................................................... 8&#13;
2.4 Microbial imbalance: dysbiosis and disease ................................................................. 11&#13;
2.4.1 Enteropathogenic Escherichia coli ................................................................................ 11&#13;
2.4.2 Antibiotics: the good and bad ....................................................................................... 13&#13;
2.5 Probiotics: a controversial issue in IBD? Benefits and importance ................................. 13&#13;
2.5.1 Escherichia coli Nissle 1917: a candidate on the list of probiotics................................ 15&#13;
2.6 Outer membrane vesicles ............................................................................................ 17&#13;
2.7 2D vs. 3D a new shift in the biological dimension ......................................................... 18&#13;
2.7.1 Rotating Wall Vessel- derived 3D models ..................................................................... 18&#13;
2.8 Aim of the study .......................................................................................................... 20&#13;
MATERIALS ................................................................................................................................ 22&#13;
3.1 Bacterial strains .......................................................................................................... 22&#13;
3.2 Eukaryotic cell lines ..................................................................................................... 25&#13;
3.3 Primers used for Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) ............................................................................................................................... 25&#13;
3.4 Antibodies and immune fluorescence dyes .................................................................. 26&#13;
3.5 Kits ............................................................................................................................. 27&#13;
3.6 Protein size standard ................................................................................................... 27&#13;
3.7 Culture media ............................................................................................................. 28&#13;
3.7.1 Bacterial culture media ................................................................................................. 28&#13;
3.7.2 Culture media and supplements for eukaryotic cell lines ............................................ 28&#13;
3.8 3D cell culture equipment ........................................................................................... 29&#13;
3.9 Common buffers and solutions .................................................................................... 29&#13;
METHODS .................................................................................................................................. 31&#13;
4.1 Microbiological methods ............................................................................................. 31&#13;
4.1.1 Cultivation of bacterial strains ...................................................................................... 31&#13;
4.1.2 Storage of bacterial strains ........................................................................................... 31&#13;
4.1.3 Outer membrane vesicles isolation .............................................................................. 31&#13;
4.1.4 Supernatant preparation .............................................................................................. 32&#13;
4.2 Cell biology methods ................................................................................................... 32&#13;
4.2.1 Culture of eukaryotic cell lines ...................................................................................... 32&#13;
4.2.2 Freezing, storage and thawing of eukaryotic cells ........................................................ 33&#13;
4.2.3 Quantification of eukaryotic cell concentration ........................................................... 33&#13;
4.2.4 Culturing of eukaryotic cells on permeable membrane supports ................................ 34&#13;
4.2.5 Culturing of eukaryotic cells on dextran microcarrier beads ........................................ 35&#13;
4.2.6 Immunofluorescence microscopy ................................................................................. 35&#13;
4.2.6.1 Immunofluorescence of cells grown on coverslips or transwell filters .................... 36&#13;
4.2.6.2 Immunofluorescence of cells grown in the RWV bioreactor .................................... 36&#13;
4.2.7 Electron microscopy ...................................................................................................... 37&#13;
4.3 Molecular Biology methods ......................................................................................... 37&#13;
4.3.1 RNA isolation from eukaryotic cells .............................................................................. 37&#13;
4.3.2 RNA quality control ....................................................................................................... 38&#13;
4.3.3 Reverse transcription .................................................................................................... 38&#13;
4.3.4 Quantitative real-time PCR ........................................................................................... 40&#13;
4.4 Protein methods ......................................................................................................... 42&#13;
4.4.1 Precipitation with trichloroacetic acid .......................................................................... 42&#13;
4.4.2 Preparation of eukaryotic cell lysates ........................................................................... 42&#13;
4.4.3 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis ....................................... 42&#13;
4.4.4 SDS-PAGE gel staining with Coomasie .......................................................................... 43&#13;
4.4.5 Western blotting ........................................................................................................... 43&#13;
4.5 Experimental procedures and sample analysis ............................................................. 45&#13;
4.5.1 Infection of eukaryotic cells with living bacteria .......................................................... 45&#13;
4.5.2 Infection of eukaryotic cells with OMVs and cell-free supernatants ............................ 45&#13;
4.5.3 Pre-infection of eukaryotic cells with EPEC strain E2348/69 ........................................ 45&#13;
4.5.4 Rotating infection .......................................................................................................... 46&#13;
4.6 Bioinformatic analysis ................................................................................................. 46&#13;
4.6.1 Data presentation ......................................................................................................... 46&#13;
4.6.2 Calculation of statistic significances .............................................................................. 46&#13;
4.6.3 Calculation of mRNA expression ................................................................................... 46&#13;
RESULTS .................................................................................................................................... 48&#13;
5.1 Kinetics of JAM-A expression in HT29-MTX-E12 cells after infection with enteropathogenic E. coli strain E2348/69 ............................................................................................................ 48&#13;
5.2 Kinetics of JAM-A expression in HT29-MTX-E12 cells after incubation with the probiotic E. coli strain Nissle 1917 variant 3595 ......................................................................................... 51&#13;
5.3 Response of mucin-producing HT29-MTX-E12 cells to the EPEC strain E2348/69 and the different variants of the probiotic EcN .................................................................................... 53&#13;
5.3.1 JAM-A response in HT29-MTX-E12 cells ....................................................................... 53&#13;
5.3.2 Myeloid differentiation primary response (MyD88) expression in HT29-MTX-E12 cells 55&#13;
5.3.3 Occludin response in HT29-MTX-E12 cells .................................................................... 57&#13;
5.4 Evaluation of the quality of the isolated RNA from HT29-MTX-E12 cells ........................ 58&#13;
5.5 Physical features of HT29-MTX-E12 cultured on Cytodex-3 dextran microcarrier beads and employing the Rotating Wall Vessel bioreactor ....................................................................... 60&#13;
5.6 Localization of JAM-A protein in HT29-MTX-E12 cells incubated with pathogenic and probiotic bacteria ................................................................................................................... 62&#13;
5.7 Outer membrane vesicles isolation from the E. coli strains E2348/69, EcN WT and EcN variant 3595 ........................................................................................................................... 66&#13;
5.7.1 JAM-A expression in HT29-MTX-E12 cells incubated with OMVs of EPEC strain E2348/69, EcN WT and EcN variant 3595 ..................................................................................... 67&#13;
5.7.2 MyD88 expression in HT29-MTX-E12 cells incubated with OMVs of EPEC strain E2348/69, EcN WT and EcN variant 3595 ..................................................................................... 68&#13;
5.8 Incubation of HT29-MTX-E12 cells with supernatants of the strains EPEC E2348/69, EcN WT and EcN variant PZ816 ............................................................................................................ 69&#13;
5.8.1 JAM-A expression in HT29-MTX-E12 cells incubated with supernatants of EPEC strain E2348/69, EcN WT and EcN variant PZ816 ................................................................................... 71&#13;
5.8.2 MyD88 expression in HT29-MTX-E12 cells incubated with supernatants of EPEC strain E2348/69, EcN WT and EcN variant PZ816 ................................................................................... 72&#13;
5.9 JAM-A expression in HT29-MTX-E12 cells pre-infected with EPEC strain E2348/69 and followed by incubation with EcN WT....................................................................................... 74&#13;
5.10 Localization of JAM-A protein in HT29-MTX-E12 cells pre-incubated with the EPEC strain E2348/69 ............................................................................................................................... 75&#13;
5.11 EPEC strain E2348/69 time kinetics and JAM-A distribution in HT29-MTX-E12 cells ....... 78&#13;
5.12 Effect of EcN on JAM-A distribution after infection of HT29-MTX-E12 cells with the EPEC strain E2348/69 ...................................................................................................................... 79&#13;
5.13 Effect of two EcN variants on JAM-A distribution after infection of HT29-MTX-E12 cells with the EPEC strain E2348/69 ................................................................................................ 80&#13;
5.14 Effect of OMVs and the supernatant of EcN WT on JAM-A expression and distribution after infection of HT29-MTX-E12 cells with the EPEC strain E2348/69 ............................................... 82&#13;
5.15 Effect of OMVs and the supernatant of EcN WT on MyD88 expression after infection of HT29-MTX-E12 cells with the EPEC strain E2348/69 ................................................................. 85&#13;
5.16 Static vs. rotating infection .......................................................................................... 86&#13;
5.16.1 JAM-A expression and distribution after incubation of HT29-MTX-E12 cells with EPEC strain E2348/69, EcN WT and EcN 3595 ....................................................................................... 86&#13;
5.16.2 MyD88 expression after incubation of HT29-MTX-E12 cells with EPEC strain E2348/69, EcN WT and EcN 3595 ................................................................................................................... 89&#13;
5.17 RT2 profiler arrays to analyze bacteria – host interactions at the transcriptional level ... 90&#13;
5.18 Cellular gene expression profiles in the presence or absence of mucin .......................... 93&#13;
5.19 JAM-A detection in HT29-MTX-E12 cells by Western blot ............................................. 98&#13;
5.20 Response of mucin-producing LS174T cells to the EPEC strain E2348/69 and the different variants of the probiotic strain EcN ....................................................................................... 103&#13;
5.21 JAM-A and MyD88 expression in LS174T cells incubated with OMVs of EPEC strain E2348/69, EcN WT and EcN variant 3595 ............................................................................... 107&#13;
5.22 JAM-A and MyD88 expression in LS174T cells incubated with supernatants of EPEC strain E2348/69, EcN WT and EcN variant PZ816 ............................................................................. 108&#13;
5.23 JAM-A detection in LS174T cells by Western blot ....................................................... 110&#13;
DISCUSSION ............................................................................................................................. 113&#13;
6.1 Gene expression and protein distribution in eukaryotic cells growing in different cell culture systems .................................................................................................................... 113&#13;
6.2 Importance of mucin production to study host-microbe interactions in the gut........... 115&#13;
6.2.1 Infection of eukaryotic cells with EPEC strain E2348/69 ............................................ 115&#13;
6.2.2 Cellular response of HT29-MTX-E12 cells to EPEC strain E2348/69 outer membrane vesicles and supernatant ............................................................................................................ 119&#13;
6.3 Incubation of eukaryotic cells with variants of the probiotic strain EcN ....................... 121&#13;
6.3.1 Cellular response of HT29-MTX-E12 cells to EcN outer membrane vesicles and supernatant ................................................................................................................................. 125&#13;
6.4 Occludin expression in HT29-MTX-E12 cells after incubation with EPEC strain E2348/69 and probiotic strain EcN .............................................................................................................. 127&#13;
6.5 Cellular response of HT29-MTX-E12 cells after incubation under rotating conditions with EPEC strain E2348/69 and probiotic EcN ................................................................................ 128&#13;
6.6 Cellular response of LS174T cells to incubation with EPEC strain E2348/69 and probiotic strain EcN ............................................................................................................................. 130&#13;
6.7 Summary and outlook ............................................................................................... 131&#13;
7. References ........................................................................................................................... 134&#13;
8. Appendix ............................................................................................................................. 146&#13;
8.1 Additional information .............................................................................................. 146&#13;
8.2 Scientific contribution ............................................................................................... 147&#13;
8.3 Acknowledgements ................................................................................................... 148</mods:tableOfContents>
                  <mods:targetAudience>specialized</mods:targetAudience>
                  <mods:note type="thesis">Münster (Westfalen), Univ., Diss., 2020</mods:note>
                  <mods:subject>
                    <mods:topic lang="ger">E. coli Nissle 1917; Probiotika; 3D-Zellkultursystem; EPEC; Barrierefunktion; immunomodulatorische Eigenschaften</mods:topic>
                  </mods:subject>
                  <mods:classification authority="ddc">570</mods:classification>
                  <mods:relatedItem type="preceding">
                    <mods:recordInfo>
                      <mods:recordIdentifier>oai:wwu.de:5b8f58f5-4a1e-4be4-b080-7d1df5c75b7a</mods:recordIdentifier>
                    </mods:recordInfo>
                  </mods:relatedItem>
                  <mods:identifier type="urn">urn:nbn:de:hbz:6-79089737739</mods:identifier>
                  <mods:location>
                    <mods:url access="object in context">https://miami.uni-muenster.de/Record/9bce4314-8186-4ab5-94f2-ffb9fb72900f</mods:url>
                  </mods:location>
                  <mods:accessCondition type="use and reproduction">
                    <mods:extension>
                      <ma:maWrap xmlns:ma="http://memoryalpha.ulb.uni-muenster.de">
                        <ma:licence>
                          <ma:displayLabel>CC BY-NC-ND 4.0</ma:displayLabel>
                          <ma:targetUrl>http://creativecommons.org/licenses/by-nc-nd/4.0</ma:targetUrl>
                        </ma:licence>
                      </ma:maWrap>
                    </mods:extension>
                  </mods:accessCondition>
                  <mods:recordInfo>
                    <mods:recordIdentifier>oai:wwu.de:9bce4314-8186-4ab5-94f2-ffb9fb72900f</mods:recordIdentifier>
                  </mods:recordInfo>
                </mods:mods>
              </mets:xmlData>
            </mets:mdWrap>
          </mets:dmdSec>
          <mets:amdSec ID="AMD_9bce4314-8186-4ab5-94f2-ffb9fb72900f">
            <mets:rightsMD ID="RIGHTSMD_9bce4314-8186-4ab5-94f2-ffb9fb72900f">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVRIGHTS">
                <mets:xmlData>
                  <dv:rights xmlns:dv="http://dfg-viewer.de/">
                    <dv:owner>Universitäts- und Landesbibliothek Münster</dv:owner>
                  </dv:rights>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:rightsMD>
            <mets:digiprovMD ID="DIGIPROVMD_9bce4314-8186-4ab5-94f2-ffb9fb72900f">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVLINKS">
                <mets:xmlData>
                  <dv:links xmlns:dv="http://dfg-viewer.de/">
                    <dv:reference>https://miami.uni-muenster.de/Record/9bce4314-8186-4ab5-94f2-ffb9fb72900f</dv:reference>
                    <dv:presentation/>
                  </dv:links>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:digiprovMD>
          </mets:amdSec>
          <mets:fileSec>
            <mets:fileGrp USE="DEFAULT">
              <mets:file MIMETYPE="application/pdf" CHECKSUM="019180f3d41cc8644b3ec7f7c467e0289418fd6830da57bde8f49bf4f0875af0" CREATED="2020-10-07T07:17:06" CHECKSUMTYPE="SHA-256" SIZE="9872530" ID="ID_FIL_diss_gonzalez.pdf_DEFAULT">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/9bce4314-8186-4ab5-94f2-ffb9fb72900f/diss_gonzalez.pdf" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
            <mets:fileGrp USE="DOWNLOAD">
              <mets:file MIMETYPE="application/pdf" ID="DOW9bce4314-8186-4ab5-94f2-ffb9fb72900f">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/transfer/miami/9bce4314-8186-4ab5-94f2-ffb9fb72900f" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
          </mets:fileSec>
          <mets:structMap TYPE="PHYSICAL">
            <mets:div ID="ID_PHY_9bce4314-8186-4ab5-94f2-ffb9fb72900f" TYPE="physSequence">
              <mets:div ID="ID_PHY_diss_gonzalez.pdf">
                <mets:fptr FILEID="ID_FIL_diss_gonzalez.pdf_DEFAULT"/>
              </mets:div>
            </mets:div>
          </mets:structMap>
          <mets:structMap TYPE="LOGICAL">
            <mets:div ADMID="AMD_9bce4314-8186-4ab5-94f2-ffb9fb72900f" DMDID="DMD_9bce4314-8186-4ab5-94f2-ffb9fb72900f" ID="ID_LOG_9bce4314-8186-4ab5-94f2-ffb9fb72900f" TYPE="Monograph">
              <mets:div ID="ID_LOG_ID_PHY_diss_gonzalez.pdf"/>
            </mets:div>
          </mets:structMap>
          <mets:structLink>
            <mets:smLink xlink:from="ID_LOG_9bce4314-8186-4ab5-94f2-ffb9fb72900f" xlink:to="ID_PHY_9bce4314-8186-4ab5-94f2-ffb9fb72900f"/>
            <mets:smLink xlink:from="ID_LOG_ID_PHY_diss_gonzalez.pdf" xlink:to="ID_PHY_diss_gonzalez.pdf"/>
          </mets:structLink>
        </mets:mets>